| Financial Year |
March 31 2023 |
| Monetary Funds |
140,098,797.46 |
| Held-for-trading Financial Assets |
659,991.02 |
| Notes Receivable |
-- |
| Accounts Receivable |
60,708,146.37 |
| Advances to Suppliers |
242,793,105.60 |
| Other Receivables |
14,234,000.30 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
326,478,330.24 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,416,741.87 |
| Total Current Assets |
797,389,112.86 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
172,824,966.22 |
| Investment Properties |
10,036,583.00 |
| Fixed Assetes |
275,354,853.94 |
| Under-construction Projects |
397,936.77 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
84,071,526.51 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,855,302.35 |
| Deferred Income Tax Assets |
30,850,372.48 |
| Other Non-Current Assets |
100,002,563.02 |
| Sub-Total of Non-Current Assets |
757,946,182.89 |
| Total Assets |
1,555,335,295.75 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
6,568,546.95 |
| Accounts Received In Advance |
45,340.50 |
| Employee Compensation Payable |
1,754,778.04 |
| Taxes Payable |
1,156,169.24 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
11,548,231.65 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,754,903.54 |
| Other Current Liabilities |
361,617.18 |
| Sub-Total of Current Liabilities |
31,241,677.92 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
18,998,913.94 |
| Total Liabilities |
50,240,591.86 |
| Paid-In Capital(Or Share Stock) |
587,060,741.00 |
| Capital Surplus |
237,374,937.76 |
| Surplus Reserve |
106,583,374.06 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
573,194,015.89 |
| Minority Stockholder's Interest |
881,635.18 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,504,213,068.71 |
| Owner's Equity（Stockholder's Equity） |
1,505,094,703.89 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,555,335,295.75 |
